Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Net Income (2023 - 2024)

Historic Net Income for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to -$16.1 million.

  • Artiva Biotherapeutics' Net Income fell 4130.15% to -$16.1 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$16.1 million, marking a year-over-year increase of 7188.64%. This contributed to the annual value of -$65.4 million for FY2024, which is 12762.19% down from last year.
  • As of Q4 2024, Artiva Biotherapeutics' Net Income stood at -$16.1 million, which was down 4130.15% from -$16.5 million recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' Net Income registered a high of $11.2 million during Q3 2023, and its lowest value of -$16.5 million during Q3 2024.